Thermoneutral housing promotes hepatic steatosis in standard diet-fed C57BL/6N mice, with a less pronounced effect on NAFLD progression upon high-fat feeding

Front Endocrinol (Lausanne). 2023 Jul 12:14:1205703. doi: 10.3389/fendo.2023.1205703. eCollection 2023.

Abstract

Introduction: Non-alcoholic fatty liver disease (NAFLD) can progress to more severe stages, such as steatohepatitis and fibrosis. Thermoneutral housing together with high-fat diet promoted NAFLD progression in C57BL/6J mice. Due to possible differences in steatohepatitis development between different C57BL/6 substrains, we examined how thermoneutrality affects NAFLD progression in C57BL/6N mice.

Methods: Male mice were fed standard or high-fat diet for 24 weeks and housed under standard (22°C) or thermoneutral (30°C) conditions.

Results: High-fat feeding promoted weight gain and hepatic steatosis, but the effect of thermoneutral environment was not evident. Liver expression of inflammatory markers was increased, with a modest and inconsistent effect of thermoneutral housing; however, histological scores of inflammation and fibrosis were generally low (<1.0), regardless of ambient temperature. In standard diet-fed mice, thermoneutrality increased weight gain, adiposity, and hepatic steatosis, accompanied by elevated de novo lipogenesis and changes in liver metabolome characterized by complex decreases in phospholipids and metabolites involved in urea cycle and oxidative stress defense.

Conclusion: Thermoneutrality appears to promote NAFLD-associated phenotypes depending on the C57BL/6 substrain and/or the amount of dietary fat.

Keywords: C57BL/6N mice; NASH; de novo lipogenesis; liver steatosis; metabolomics; non-alcoholic fatty liver disease; obesity; thermoneutrality.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Diet, High-Fat / adverse effects
  • Housing
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Non-alcoholic Fatty Liver Disease* / metabolism
  • Weight Gain

Grants and funding

This work was supported by the Ministry of Health of the Czech Republic (grant no. NU21-01-00469), the project FOIE GRAS, which has received funding from the European Union’s Horizon 2020 Research and Innovation framework, under the Marie Skłodowska-Curie Grant Agreement (grant no. 722619; recipient GS), and by the project National Institute for Research of Metabolic and Cardiovascular Diseases (Programme EXCELES, ID Project no. LX22NPO5104) - funded by the European Union - Next Generation EU.